ArticleTherapeutic advances in endocrinology and metabolism2015

Patient preference and tolerability of a DPP-4 inhibitor versus a GLP-1 analog in patients with type 2 diabetes mellitus inadequately controlled with metformin: a 24-week, randomized, multicenter, crossover study.

Jörg Lüdemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.